Giving millions of patients already taking statins a new type of drug could slash their heart disease risk even further, research suggests.

Scientists claim pills that are currently under development, called lipoprotein lipase (LPL) enhancers, could prevent thousands of heart attacks.

And their study also showed the drugs — which work by lowering levels of fats in the blood — could also slash the risk of type 2 diabetes.

Read more